DNUT vs CAKE

For growth investors, The Cheesecake Factory Incorporated (CAKE) is the stronger pick with 4.

7% revenue growth year-over-year, versus -8. 6% for Krispy Kreme, Inc. (DNUT). The Cheesecake Factory Incorporated (CAKE) offers the better valuation at 19. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Krispy Kreme, Inc. (DNUT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, The Cheesecake Factory Incorporated (CAKE) delivered a total return of +2.

1%, compared to -80. 2% for Krispy Kreme, Inc. (DNUT). Over 10 years, the gap is even starker: CAKE returned +35. 6% versus DNUT's -80. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Cheesecake Factory Incorporated (CAKE) is the lower-risk stock at 1.

11β versus Krispy Kreme, Inc. 's 1. 51β — meaning DNUT is approximately 35% more volatile than CAKE relative to the S&P 500. On balance sheet safety, Krispy Kreme, Inc. (DNUT) carries a lower debt/equity ratio of 2% versus 8% for The Cheesecake Factory Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Cheesecake Factory Incorporated (CAKE) is pulling ahead at 4.

7% versus -8. 6% for Krispy Kreme, Inc. (DNUT). On earnings-per-share growth, the picture is similar: The Cheesecake Factory Incorporated grew EPS -4. 1% year-over-year, compared to -170. 8% for Krispy Kreme, Inc.. Over a 3-year CAGR, CAKE leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Cheesecake Factory Incorporated (CAKE) is the more profitable company, earning 4.

0% net margin versus -33. 9% for Krispy Kreme, Inc. — meaning it keeps 4. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAKE leads at 5. 0% versus -2. 2% for DNUT. At the gross margin level — before operating expenses — CAKE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for DNUT: 23.

6% to $4. 50.

All stocks in this comparison pay dividends.

Krispy Kreme, Inc. (DNUT) offers the highest yield at 1. 9%, versus 1. 8% for The Cheesecake Factory Incorporated (CAKE).

For long-horizon retirement investors, The Cheesecake Factory Incorporated (CAKE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

11), 1. 8% yield). Krispy Kreme, Inc. (DNUT) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAKE: +35. 6%, DNUT: -80. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DNUT (Consumer Defensive) and CAKE (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.